INS and lipodystrophy: By crossing lipodystrophy mice (A-ZIP/F1) with mice expressing a dominant negative MSTN receptor (activin receptor type IIB) in muscle, inhibition of MSTN action in A-ZIP/F1 mice notably lower the levels of blood glucose, serum insulin, triglyceride, and triglyceride synthesis rate, and enhanced insulin sensitivity (66).